Echocardiographic findings in the clinically examined group of participants with NT-proBNP ≥900 ng/L (n=93)
| Echocardiographic variables | |
| LVEF≥ 50%, n (%) | 80 (86) |
| LVEF 40%–49%, n (%) | 3 (3.2) |
| LVEF <40%, n (%) | 10 (10.8) |
| Atrial volume mL/m2, median (Q1–Q3) | 36 (30–48) |
| Left ventricular mass, g/m2, median (Q1–Q3) | 96 (80–124.5) |
| Mitral E/é ratio, median (Q1–Q3) | 11.2 (9–14) |
| Pulmonary artery pressure, mm Hg, median (Q1–Q3) | 33 (28.8–39.5) |
| Patients with atrial volume >34 mL/m2, n (%) | 53 (58) |
| Patients with left ventricular mass >115 g/m2 in men and >95 g/m2 in women, n (%) | 33 (41.3) |
| Patients with E/é >13, n (%) | 28 (39) |
| Patients with pulmonary artery pressure >35 mm Hg, n (%) | 27 (39) |
é, average peak early diastolic tissue velocity; E, mitral peak velocity; LVEF, left ventricular ejection fraction; NT-proBNP, N-terminal pro-B-type natriuretic peptide; Q1, first quartile; Q3, third quartile.